MEDACTA GROUP SA

MOVE
Delayed Quote. Delayed  - 12/03 11:30:41 am
127.4CHF -1.85%
Valuation
Fiscal Period: December 2020 2021
Capitalization1 1 6152 454
Entreprise Value (EV)2 1 6982 530
P/E ratio 43,6x42,9x
Yield -0,60%
Capitalization / Revenue 5,34x6,69x
EV / Revenue 5,61x6,90x
EV / EBITDA 19,3x23,1x
Price to Book 9,80x11,3x
Nbr of stocks (in thousands) 20 00019 997
Reference price (EUR) 80,7123
Announcement Date 03/30/2021-
Previous period Next period
1 CHF in Million
2 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 303367
EBITDA1 88,1110
Operating profit (EBIT)1 51,168,5
Operating Margin 16,9%18,7%
Pre-Tax Profit (EBT) 39,9-
Net income1 37,158,1
Net margin 12,3%15,8%
EPS2 1,852,86
Dividend per Share2 -0,73
Announcement Date 03/30/2021-
Previous period Next period
1 EUR in Million
2 EUR
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 83,376,1
Net Cash position1 --
Leverage (Debt / EBITDA) 0,95x0,69x
Free Cash Flow1 25,452,0
ROE (Net Profit / Equities) 25,8%30,3%
Shareholders' equity1 144192
ROA (Net Profit / Asset) 8,68%11,5%
Assets1 427504
Book Value Per Share2 8,2410,9
Cash Flow per Share2 2,984,35
Capex1 34,243,5
Capex / Sales 11,3%11,9%
Announcement Date 03/30/2021-
Previous period Next period
1 EUR in Million
2 EUR
Financial Ratios
Size 2021e 2022e
Capitalization 2 454 M € -
Entreprise Value (EV) 2 530 M € 2 521 M €
Valuation 2021e 2022e
P/E ratio (Price / EPS) 42,9x 33,9x
Capitalization / Revenue 6,69x 5,88x
EV / Revenue 6,90x 6,06x
EV / EBITDA 23,1x 19,4x
Yield (DPS / Price) 0,60% 0,81%
Price to book (Price / BVPS) 11,3x 8,95x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 18,7% 20,6%
Operating Leverage (Delta EBIT / Delta Sales) 1,61x 1,86x
Net Margin (Net Profit / Revenue) 15,8% 17,3%
ROA (Net Profit / Asset) 11,5% 12,4%
ROE (Net Profit / Equities) 30,3% 28,6%
Rate of Dividend 25,6% 27,5%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   11,9% 11,6%
Cash Flow / Sales 23,7% 24,2%
Capital Intensity (Assets / Sales) 1,37x 1,39x
Financial Leverage (Net Debt / EBITDA) 0,69x 0,52x
Price Earning Ratio
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS & Dividend